Glaxo Boasts Cervarix Protects Against Five Most Common HPV Strains
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Yet another missive has been fired in the HPV vaccine wars. A new study finds that GlaxoSmithKline's Cervarix vaccine offers protection against five of the most common strains of human papillomarvirus that can lead to cervical cancer